We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
214 hedge funds and large institutions have $1.16B invested in ADMA Biologics in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 85 increasing their positions, 54 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,163% more call options, than puts
Call options by funds: $3.04M | Put options by funds: $93K
168% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 19
57% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 54
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
48% more capital invested
Capital invested by funds: $782M → $1.16B (+$374M)
16% more funds holding
Funds holding: 184 → 214 (+30)
0.2% more ownership
Funds ownership: 76.53% → 76.74% (+0.2%)
Holders
214
Holders Change
+30
Holders Change %
+16.3%
% of All Funds
3.08%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
51
Increased
85
Reduced
54
Closed
19
Calls
$3.04M
Puts
$93K
Net Calls
+$2.94M
Net Calls Change
+$2.34M
Top Buyers
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$31.7M |
| 2 |
Morgan Stanley
New York
|
-$20.5M |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$10.5M |
| 4 |
Millennium Management
New York
|
-$9.52M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$8.87M |
